A Prospective Observational Study of Foam Sclerotherapy .

Abroad (travel likely)Recruiting

Conditions

Autosomal Dominant Polycystic Kidney · Renal Cyst · Autosomal Dominant Polycystic Liver Disease · Hepatic Cyst

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Marie C Hogan, MD, PhD) · hogan.marie@mayo.edu · 507-266-1963
Contact: Principal Investigator (Marie C. Hogan, M.D., Ph.D.)

Study leads

Marie Hogan, MD, PhD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease

Polycystic Liver Disease · Autosomal Dominant Polycystic Kidney

Abroad (travel likely)RecruitingPHASE2

Nijmegen, Netherlands · Groningen, Netherlands

Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Abroad (travel likely)RecruitingPHASE2

Alabaster, United States · Birmingham, United States

Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Abroad (travel likely)RecruitingPHASE1

Southport, Australia · Concord, Australia

ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease

Abroad (travel likely)RecruitingPHASE2

Garden Grove, United States · Huntington Park, United States